Catalyst Wire Dossier Catalyst Wire Dossier

KQ-791

· Kaneq Bioscience Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KQ-791, covering 2019-10-30 to 2019-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of KQ-791 in Diabetes Mellitus [Phase 1]

See pricing